A detailed history of Alliancebernstein L.P. transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Alliancebernstein L.P. holds 6,983,259 shares of EW stock, worth $518 Million. This represents 0.16% of its overall portfolio holdings.

Number of Shares
6,983,259
Previous 20,341,148 65.67%
Holding current value
$518 Million
Previous $1.88 Billion 75.47%
% of portfolio
0.16%
Previous 0.68%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$59.7 - $93.78 $797 Million - $1.25 Billion
-13,357,889 Reduced 65.67%
6,983,259 $461 Million
Q2 2024

Aug 14, 2024

BUY
$84.3 - $94.31 $332 Million - $371 Million
3,935,417 Added 23.99%
20,341,148 $1.88 Billion
Q1 2024

May 14, 2024

SELL
$72.54 - $95.56 $195 Million - $256 Million
-2,682,912 Reduced 14.06%
16,405,731 $1.57 Billion
Q4 2023

Feb 14, 2024

SELL
$61.71 - $77.76 $225 Million - $284 Million
-3,653,069 Reduced 16.06%
19,088,643 $1.46 Billion
Q3 2023

Nov 14, 2023

BUY
$69.28 - $93.38 $154 Million - $208 Million
2,229,477 Added 10.87%
22,741,712 $1.58 Billion
Q2 2023

Aug 15, 2023

BUY
$81.41 - $94.33 $5.44 Million - $6.3 Million
66,763 Added 0.33%
20,512,235 $1.93 Billion
Q1 2023

May 15, 2023

SELL
$74.26 - $84.51 $106 Million - $121 Million
-1,428,808 Reduced 6.53%
20,445,472 $1.69 Billion
Q4 2022

Feb 14, 2023

BUY
$68.3 - $87.44 $322 Million - $412 Million
4,712,819 Added 27.46%
21,874,280 $1.63 Billion
Q3 2022

Nov 15, 2022

BUY
$82.37 - $107.29 $65.8 Million - $85.8 Million
799,376 Added 4.89%
17,161,461 $1.42 Billion
Q2 2022

Aug 15, 2022

BUY
$86.5 - $128.27 $198 Million - $293 Million
2,283,544 Added 16.22%
16,362,085 $1.56 Billion
Q1 2022

May 13, 2022

BUY
$101.96 - $128.34 $69.3 Million - $87.3 Million
680,021 Added 5.08%
14,078,541 $1.66 Billion
Q4 2021

Feb 14, 2022

BUY
$106.37 - $130.68 $62 Million - $76.2 Million
583,209 Added 4.55%
13,398,520 $1.74 Billion
Q3 2021

Nov 10, 2021

SELL
$102.91 - $122.75 $20.5 Million - $24.5 Million
-199,542 Reduced 1.53%
12,815,311 $1.45 Billion
Q2 2021

Jul 30, 2021

SELL
$83.84 - $104.76 $5.16 Million - $6.45 Million
-61,530 Reduced 0.47%
13,014,853 $1.35 Billion
Q1 2021

May 06, 2021

BUY
$78.68 - $90.67 $18.9 Million - $21.7 Million
239,765 Added 1.87%
13,076,383 $1.09 Billion
Q4 2020

Feb 08, 2021

SELL
$71.69 - $91.23 $87.3 Million - $111 Million
-1,218,037 Reduced 8.67%
12,836,618 $1.17 Billion
Q3 2020

Nov 12, 2020

BUY
$67.19 - $87.44 $30 Million - $39 Million
446,225 Added 3.28%
14,054,655 $1.12 Billion
Q2 2020

Aug 13, 2020

BUY
$57.54 - $76.95 $535 Million - $715 Million
9,292,643 Added 215.32%
13,608,430 $940 Million
Q1 2020

May 14, 2020

BUY
$52.41 - $81.0 $43.1 Million - $66.6 Million
822,551 Added 23.55%
4,315,787 $814 Million
Q4 2019

Feb 18, 2020

SELL
$71.7 - $82.09 $36 Million - $41.3 Million
-502,741 Reduced 12.58%
3,493,236 $815 Million
Q3 2019

Nov 14, 2019

SELL
$61.55 - $75.43 $22.6 Million - $27.7 Million
-367,756 Reduced 8.43%
3,995,977 $879 Million
Q2 2019

Aug 14, 2019

BUY
$55.74 - $64.41 $4 Million - $4.63 Million
71,811 Added 1.67%
4,363,733 $806 Million
Q1 2019

May 14, 2019

SELL
$47.89 - $64.05 $27.1 Million - $36.3 Million
-566,214 Reduced 11.65%
4,291,922 $821 Million
Q4 2018

Feb 13, 2019

BUY
$46.41 - $56.94 $6.72 Million - $8.25 Million
144,807 Added 3.07%
4,858,136 $744 Million
Q3 2018

Nov 08, 2018

SELL
$45.7 - $58.03 $4.49 Million - $5.7 Million
-98,201 Reduced 2.04%
4,713,329 $821 Million
Q2 2018

Aug 13, 2018

SELL
$42.45 - $51.3 $6.23 Million - $7.52 Million
-146,664 Reduced 2.96%
4,811,530 $700 Million
Q1 2018

May 14, 2018

SELL
$37.19 - $47.45 $48.4 Million - $61.8 Million
-1,301,577 Reduced 20.79%
4,958,194 $692 Million
Q4 2017

Feb 13, 2018

BUY
$33.79 - $39.39 $22.8 Million - $26.6 Million
675,216 Added 12.09%
6,259,771 $706 Million
Q3 2017

Nov 13, 2017

BUY
$36.29 - $38.83 $203 Million - $217 Million
5,584,555
5,584,555 $610 Million

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $45.8B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Alliancebernstein L.P. Portfolio

Follow Alliancebernstein L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alliancebernstein L.P., based on Form 13F filings with the SEC.

News

Stay updated on Alliancebernstein L.P. with notifications on news.